(0.07%) 5 472.88 points
(0.09%) 39 146 points
(0.37%) 17 784 points
(0.00%) $80.83
(-3.66%) $2.66
(-0.76%) $2 313.00
(0.25%) $28.94
(3.64%) $1 022.30
(0.28%) $0.936
(0.70%) $10.68
(0.45%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
Revelation Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunologic-based therapeutics and diagnostics for the prevention and treatment of disease...
Stats | |
---|---|
今日成交量 | 56 612 |
平均成交量 | 0 |
市值 | 4.11M |
EPS | $-2.46 ( Q1 | 2024-05-10 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0.00200 (11.98%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-08 | Tidmarsh George F | Sell | 27 771 | Common Stock |
2023-10-16 | Tidmarsh George F | Sell | 1 845 | Common Stock |
2023-10-16 | Tidmarsh George F | Sell | 10 957 | Common Stock |
2023-09-27 | Chawla Lakhmir S | Buy | 0 | |
2023-09-28 | Tidmarsh George F | Sell | 1 429 | Common Stock |
INSIDER POWER |
---|
-15.58 |
Last 16 transactions |
Buy: 80 077 | Sell: 799 452 |
Revelation Biosciences, 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Revelation Biosciences, 财务报表
Annual | 2023 |
营收: | $0 |
毛利润: | $-25 049.00 (0.00 %) |
EPS: | $-0.530 |
FY | 2023 |
营收: | $0 |
毛利润: | $-25 049.00 (0.00 %) |
EPS: | $-0.530 |
FY | 2022 |
营收: | $0 |
毛利润: | $-40 008.00 (0.00 %) |
EPS: | $-600.77 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $-0.310 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Revelation Biosciences,
Revelation Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunologic-based therapeutics and diagnostics for the prevention and treatment of disease. The company\'s lead therapeutic candidate is REVTx-99, an intranasal immunomodulator to prevent or treat infections caused by various respiratory viruses, such as SARS-CoV-2 comprising its variants, influenza A and B, parainfluenza, rhinovirus, and RSV, as well as is being developed for other indications comprising allergic rhinitis and chronic nasal congestion. It also develops REVTx-200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for immunity; and REVDx-501, a rapid home use diagnostic to detect respiratory viral infection. The company was founded in 2019 and is based in New York, New York.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。